rs2844337

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_002576.5(PAK1):​c.*611T>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.292 in 242,172 control chromosomes in the GnomAD database, including 10,942 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.29 ( 6448 hom., cov: 31)
Exomes 𝑓: 0.30 ( 4494 hom. )

Consequence

PAK1
NM_002576.5 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.204

Publications

11 publications found
Variant links:
Genes affected
PAK1 (HGNC:8590): (p21 (RAC1) activated kinase 1) This gene encodes a family member of serine/threonine p21-activating kinases, known as PAK proteins. These proteins are critical effectors that link RhoGTPases to cytoskeleton reorganization and nuclear signaling, and they serve as targets for the small GTP binding proteins Cdc42 and Rac. This specific family member regulates cell motility and morphology. Mutations in this gene have been associated with macrocephaly, seizures, and speech delay. Overexpression of this gene is also reported in many cancer types, and particularly in breast cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2020]
PAK1 Gene-Disease associations (from GenCC):
  • intellectual developmental disorder with macrocephaly, seizures, and speech delay
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.439 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PAK1NM_002576.5 linkc.*611T>G 3_prime_UTR_variant Exon 15 of 15 ENST00000356341.8 NP_002567.3 Q13153-1A0A024R5P0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PAK1ENST00000356341.8 linkc.*611T>G 3_prime_UTR_variant Exon 15 of 15 1 NM_002576.5 ENSP00000348696.4 Q13153-1
PAK1ENST00000530617.5 linkc.*474T>G 3_prime_UTR_variant Exon 15 of 15 2 ENSP00000433423.1 B3KNX7

Frequencies

GnomAD3 genomes
AF:
0.285
AC:
43294
AN:
151768
Hom.:
6444
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.209
Gnomad AMI
AF:
0.304
Gnomad AMR
AF:
0.239
Gnomad ASJ
AF:
0.342
Gnomad EAS
AF:
0.234
Gnomad SAS
AF:
0.455
Gnomad FIN
AF:
0.266
Gnomad MID
AF:
0.277
Gnomad NFE
AF:
0.334
Gnomad OTH
AF:
0.291
GnomAD4 exome
AF:
0.302
AC:
27296
AN:
90286
Hom.:
4494
Cov.:
0
AF XY:
0.306
AC XY:
13698
AN XY:
44782
show subpopulations
African (AFR)
AF:
0.211
AC:
637
AN:
3022
American (AMR)
AF:
0.223
AC:
1115
AN:
4996
Ashkenazi Jewish (ASJ)
AF:
0.332
AC:
1365
AN:
4110
East Asian (EAS)
AF:
0.223
AC:
2311
AN:
10362
South Asian (SAS)
AF:
0.412
AC:
2313
AN:
5614
European-Finnish (FIN)
AF:
0.245
AC:
435
AN:
1776
Middle Eastern (MID)
AF:
0.300
AC:
126
AN:
420
European-Non Finnish (NFE)
AF:
0.317
AC:
17095
AN:
54004
Other (OTH)
AF:
0.317
AC:
1899
AN:
5982
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
891
1783
2674
3566
4457
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
146
292
438
584
730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.285
AC:
43320
AN:
151886
Hom.:
6448
Cov.:
31
AF XY:
0.283
AC XY:
21013
AN XY:
74228
show subpopulations
African (AFR)
AF:
0.209
AC:
8679
AN:
41446
American (AMR)
AF:
0.239
AC:
3649
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.342
AC:
1185
AN:
3466
East Asian (EAS)
AF:
0.234
AC:
1204
AN:
5146
South Asian (SAS)
AF:
0.454
AC:
2183
AN:
4804
European-Finnish (FIN)
AF:
0.266
AC:
2804
AN:
10542
Middle Eastern (MID)
AF:
0.271
AC:
79
AN:
292
European-Non Finnish (NFE)
AF:
0.334
AC:
22645
AN:
67888
Other (OTH)
AF:
0.291
AC:
615
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1537
3073
4610
6146
7683
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
454
908
1362
1816
2270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.296
Hom.:
8969
Bravo
AF:
0.277
Asia WGS
AF:
0.360
AC:
1252
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.48
CADD
Benign
12
DANN
Benign
0.79
PhyloP100
0.20
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2844337; hg19: chr11-77033708; COSMIC: COSV53698297; COSMIC: COSV53698297; API